R87.621Billable

Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)

Short description: Atyp squam cell not excl hi grd intrepith lesn cyto smr vagn

Chapter
18. Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Category
R87
Effective date
October 1, 2026

Related codes in category R87

R87Abnormal findings in specimens from female genital organsR87.0Abn lev enzymes in specimens from female genital organsYesR87.1Abn lev hormones in specimens from female genital organsYesR87.2Abn lev drug/meds/biol subst in specmn from fem gntl organsYesR87.3Abn lev substnc nonmed source in specmn from fem gntl organsYesR87.4Abn immunolog findings in specmn from female genital organsYesR87.5Abn microbiolog find in specmn from female genital organsYesR87.6Abn cytolog findings in specmn from female genital organsR87.61Abnormal cytological findings in specimens from cervix uteriR87.610Atyp squam cell of undet signfc cyto smr crvx (ASC-US)YesR87.611Atyp squam cell not excl hi grd intrepith lesn cyto smr crvxYesR87.612Low grade intrepith lesion cyto smr crvx (LGSIL)Yes

Frequently asked questions

What is ICD-10 code R87.621?

R87.621 is an ICD-10-CM diagnosis code for Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H).

Is R87.621 a billable code?

Yes. R87.621 is billable and specific enough to be used on a claim.

What ICD-10-CM chapter is R87.621 in?

R87.621 falls under Chapter 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified.

When did R87.621 become effective?

R87.621 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.

What other codes are related to R87.621?

R87.621 belongs to category R87, which includes 12 other codes — see the related codes list on this page.

ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.